Digital pathology demonstrates innovation and a commitment to excellence in life science; with specific support for tissue based research, education, and drug development in biotechnology, pharmaceutical, and contract research organizations.
Research requires innovation and collaboration across specialties, including pathology, to develop new medical discoveries that will improve health. Digital pathology provides the innovation necessary to create high quality whole slide images of glass slides. The whole slide images are then used to identify, quantify, and document key characteristics, reactions, or responses within a specific set of tissue samples. The total time spent on research studies can be significantly decreased with digital pathology; resulting in an improved turnaround time on novel discoveries and advancements in medicine.
Time is money in the biotech, pharmaceutical, and the contract research industry. Digital Pathology streamlines the drug development process through discovery, preclinical, and clinical trials by enabling pathologists to more efficiently illustrate, communicate, and collaborate on crucial findings in tissue based toxicity and efficacy studies. A few benefits of digital pathology include high throughput scanning of glass slides, quantitative analysis of whole slide images, immediate web based consultations with expert pathologists, and secure archival of pathology data. GLP Regulatory Information
The veterinary pathology community has embraced digital pathology as a preferred academic training resource. Similar to medical schools, the majority of U.S. veterinary schools and numerous schools in other parts of the world are using digital pathology in first and second year pathology and histology courses; either as adjunct to or as a replacement for the microscope. Students can easily collaborate and access their whole slide images from anywhere.